AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

MESOBLAST LTD

2.060

-0.030-1.44%

Volume:5.89M

Turnover:12.24M

Market Cap:2.61B

PE:-14.12

High:2.130

Open:2.100

Low:2.035

Close:2.090

Loading ...

Overview Company News Filings

ASX Market Close: Miners lead bourse higher | February 5, 2025

The Market Herald

Why Block, Canyon, Fisher & Paykel Healthcare, and Mesoblast shares are falling today

High Growth Tech Stocks in Australia Featuring FINEOS Corporation Holdings and Two Others

Simply Wall St.

Is Mesoblast Limited (MESO) One of the Best ASX Stocks to Buy According to Hedge Funds?

3 ASX All Ords stocks smashing the benchmark this week

ASX Market Update: Real Estate & mining stocks lead index to another all-time high | January 31, 2025

The Market Herald

Mesoblast Plans Ryoncil Launch in March Quarter

MT Newswires Live

Why Lendlease, Mesoblast, St Barbara, and Zip shares are pushing higher

Up 1,090% in a year, why is the Mesoblast share price leaping higher again on Friday?

$1,000 invested in Mesoblast shares at the start of 2024 is now worth…

Why Mesoblast (MESO) Is Among the Best Australian Stocks to Buy Now?

3 ASX Growth Stocks With High Insider Ownership Seeing Up To 55% Earnings Growth

Simply Wall St.

Bullish Mesoblast Insiders Loaded Up On US$145.4m Of Stock

Simply Wall St.

Up 19% in a month, what's driving Mesoblast shares?

Mesoblast shares dip then flip on $800,000 insider buy

Caution! 11 stocks on the ‘avoid’ list for 2025

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.tigerhkgo.com/stock/MSB.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MSB.AU"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","market":"AU","secType":"STK","nameCN":"MESOBLAST LTD","latestPrice":2.06,"timestamp":1741583520000,"preClose":2.09,"halted":0,"volume":5890076,"delay":0,"changeRate":-0.014354,"change":-0.03,"floatShares":734902424,"shares":1268947688,"eps":-0.14583462,"lyrEps":-0.1409,"pbRate":3.59,"amount":12244880,"amplitude":0.045455,"volumeRatio":0.458514,"dividePrice":0,"prevYearClose":3.1,"fiveDayClose":2.51,"twentyDayClose":3.02},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MSB.AU\",,,,,undefined,":{"symbol":"MSB.AU","floatShares":734902424,"roa":"-4.85%","roe":"-21.31%","lyrEps":-0.140922,"volumeRatio":0.458514,"shares":1268947688,"dividePrice":0,"high":2.13,"amplitude":0.045455,"preClose":2.09,"low":2.035,"week52Low":0.315,"pbRate":"3.58","psRate":"291.63","week52High":3.37,"institutionHeld":0,"latestPrice":2.06,"committee":0.205824,"eps":-0.1458576724553596,"divideRate":0,"volume":5890076,"delay":0,"ttmEps":-0.1458576724553596,"open":2.1,"prevYearClose":3.1,"prevWeekClose":2.09,"prevMonthClose":2.52,"prevQuarterClose":3.1,"fiveDayClose":2.51,"twentyDayClose":3.02,"sixtyDayClose":1.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MSB.AU\",params:#limit:5,,,undefined,":[{"date":"2025-02-26","symbol":"MSB.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MSB.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MSB.AU\",pageSize:16,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2509421477","title":"ASX Market Close: Miners lead bourse higher | February 5, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2509421477","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509421477?lang=en_us&edition=fundamental","pubTime":"2025-02-05 14:05","pubTimestamp":1738735500,"startTime":"0","endTime":"0","summary":"The ASX200 closed up 0.51% at 8,416 points.The local market rose in response to China’s measured response to Trump’s tariffs.Materials was the best performing sector, up 1.6%, followed by IT, up 1.55%, and Energy, up 1.5%. Health Care was the biggest loser, down 0.55%.Insignia  closed up 6.9% after Brookfield Asset Management offered $4.60 a share in cash, matching current offers from Bain Capital and CC Capital Partners – and was also given limited due diligence.Woodside  closed up 1.7% as Brent Crude Oil climbed to around US$76 per barrel.Coronado Global Resources  closed up 1.5% after paring gains in morning trade. Most Aussie coal miners rallied after China’s retaliatory step to place tariffs on a basket of commodities then set expectations for higher prices.Mesoblast  closed down 5.3% despite no news today. It’s likely some investors are taking profits after the stock achieved strong gains over the last twelve months.Strickland Metals  finished down 2.7% after reporting results fr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-close-miners-lead-bourse-higher-february-5-2025-2025-02-05/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK7142","WDS.AU","BK7062","CRN.AU","BK7508","IFL.AU","BK7047","CWY.AU","BK7501","BK7067","BK7104","STK.AU","BK7129","MSB.AU"],"gpt_icon":0},{"id":"2509244514","title":"Why Block, Canyon, Fisher & Paykel Healthcare, and Mesoblast shares are falling today","url":"https://stock-news.laohu8.com/highlight/detail?id=2509244514","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509244514?lang=en_us&edition=fundamental","pubTime":"2025-02-05 10:02","pubTimestamp":1738720974,"startTime":"0","endTime":"0","summary":"TheS&P/ASX 200 Index (ASX: XJO) is on form and having a good session on Wednesday. In afternoon trade, the benchmark index is up 0.65% to 8,429 points. Four ASX shares that have failed to follow the m","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/02/05/why-block-canyon-fisher-paykel-healthcare-and-mesoblast-shares-are-falling-today/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7007","HCSG","MESO","MSB.AU","BK4139","BK7501","XJO.AU","XYZ.AU","FPH.AU","BK7067","BK7508","BK7158","CAY.AU","BK7104","BK4137"],"gpt_icon":0},{"id":"2508079521","title":"High Growth Tech Stocks in Australia Featuring FINEOS Corporation Holdings and Two Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2508079521","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508079521?lang=en_us&edition=fundamental","pubTime":"2025-02-04 12:02","pubTimestamp":1738641767,"startTime":"0","endTime":"0","summary":"The Australian market has recently shown signs of recovery, with the ASX200 rising by 0.5% to reach 8,430 points, and the IT sector leading gains at 1.6%. In this context of renewed optimism and sectoral strength, high growth tech stocks like FINEOS Corporation Holdings offer intriguing opportunities for investors seeking exposure to innovative companies in a rebounding market environment.Take a closer look at FINEOS Corporation Holdings' potential here in our health report.Understand FINEOS Corporation Holdings' track record by examining our Past report.Operations: Mesoblast Limited generates revenue primarily from the development of its cell technology platform, amounting to $5.90 million. The company operates within the regenerative medicine sector across multiple countries, including Australia and the United States.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-growth-tech-stocks-australia-040247051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MSB.AU","FCL.AU","XKO.AU","MESO","XJO.AU","BK7508","PPS.AU","XAO.AU","BK7501","BK7067","BK7016","BK7503"],"gpt_icon":0},{"id":"2507952610","title":"Is Mesoblast Limited (MESO) One of the Best ASX Stocks to Buy According to Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2507952610","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507952610?lang=en_us&edition=fundamental","pubTime":"2025-01-31 20:32","pubTimestamp":1738326722,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best ASX Stocks to Buy According to Hedge Funds.In this article, we are going to take a look at where Mesoblast Limited  stands against other best ASX stocks to buy according to hedge funds.According to a report by the Australian Bureau of Statistics  published on December 4, 2024, the Australian economy grew by 0.3% in the September quarter of 2024, which marked the twelfth consecutive quarter of growth. This growth, however, was the lowest rate since the December quarter of 2020 after the COVID-19 pandemic. The report also noted that in nominal terms, GDP rose by 0.4%.In terms of trade, a key indicator of the economy’s international competitiveness fell by 2.5% in the quarter. This decline was primarily due to a 2.6% drop in export prices and was the third consecutive quarterly fall. The weakening in global bulk commodity demand, particularly from China, significantly affected the prices of metallurgical coal and iron ore. Import prices also fell","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mesoblast-limited-meso-one-best-123202290.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":[".IXIC","BK4534","LU0912757837.SGD","LU0795875169.SGD","QID","LU1162221912.USD","LU0314104364.USD","BK7501","USAW.SI","NVIW.SI","IE00BZ1G4Q59.USD","NQmain","LU2089283258.USD","LU2347655156.SGD","LU1989772840.SGD","MESO","PSQ","USJW.SI","LU0106831901.USD","LU2133065610.SGD","LU1732799900.SGD","LU0795875086.SGD","TQQQ","BK4504","BK7067","LU1548497426.USD","LU1074936037.SGD","LU1989772923.USD","TSYW.SI","IBD","LU1732800096.USD","LU2111349929.HKD","LU0267386448.USD","BK4516","LU0158827781.USD","MSB.AU","LU0098860793.USD","SQQQ","LU0971096721.USD","XAO.AU","MNQmain","XJO.AU","XKO.AU","LU0158827948.USD","BK4127","LU0225283273.USD","IE00BKVL7J92.USD","QLD","LU1668664300.SGD"],"gpt_icon":1},{"id":"2507451987","title":"3 ASX All Ords stocks smashing the benchmark this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2507451987","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507451987?lang=en_us&edition=fundamental","pubTime":"2025-01-31 12:12","pubTimestamp":1738296732,"startTime":"0","endTime":"0","summary":"The All Ordinaries Index is up 1.4% over the Australia Day holiday-shortened trading week, with three ASX All Ords stocks doing more than their share of the heavy lifting. One provides data solutions and services for machine learning and artificial intelligence . The second is an Australian gaming technology company. And the third outperforming ASX All Ords stock on my list is a clinical-stage biotechnology company. Which high-flying stocks am I talking about?Three ASX All Ords stocks roaring higher The first ASX All Ords stock to deliver shareholders outsized gains this week is Mesoblast Ltd . Shares in the company, which specialises in allogeneic cellular medicines to treat inflammatory diseases, closed last Friday trading for $2.87. At the time of writing today, shares are changing hands for $3.12 apiece, up 10.6%. That brings the Mesoblast share price gains over the past year to…","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/31/3-asx-all-ords-stocks-smashing-the-benchmark-this-week/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7061","XAO.AU","BK7503","BK7501","ALL.AU","BK7078","APX.AU","MSB.AU","BK7508","BK7067"],"gpt_icon":0},{"id":"2507818549","title":"ASX Market Update: Real Estate & mining stocks lead index to another all-time high | January 31, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2507818549","media":"The Market Herald","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507818549?lang=en_us&edition=fundamental","pubTime":"2025-01-31 10:56","pubTimestamp":1738292160,"startTime":"0","endTime":"0","summary":"The ASX200 has hit yet another all-time high of 8,566 points in morning trade.The record was driven by a strong lead from Wall Street as well as buoyant mining and real estate stocks.Real Estate was the best performing sector, up 1.3%, followed by Materials, up 1.1%, and IT, up 0.85%. Utilities was the poorest performer, down 2.8%, followed by Telecommunication, down 0.25%.Mesoblast  has been up 2.3% on news of the U.S. launch of Ryoncil for pediatric graft-versus-host disease. The company says the focus is on finalising logistics and approvals to make the product available this quarter.Origin Energyhas been down 4.6% after revising its 2025 LNG production forecast. The company’s LNG revenue for the December 2024 quarter rose 3% from the previous quarter, reaching $2.71 billion, driven by higher LNG volumes and prices.PYC Therapeutics has been down 1.2% after to the next stage of its escalating single-dose study using its drug to treat a genetic children’s disease causing blindness.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/asx-market-update-real-estate-mining-stocks-lead-index-to-another-all-time-high-january-31-2025-2025-01-31/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["MSB.AU","BK7006","BK7508","BK7507","BK7130","PYC.AU","BK7501","BK7067","ORG.AU"],"gpt_icon":0},{"id":"2507986695","title":"Mesoblast Plans Ryoncil Launch in March Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2507986695","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507986695?lang=en_us&edition=fundamental","pubTime":"2025-01-31 10:26","pubTimestamp":1738290363,"startTime":"0","endTime":"0","summary":"Mesoblast  is set to launch its Ryoncil mesenchymal stromal cell therapy in the US during the first quarter for pediatric patients two months and older with steroid-refractory acute graft-versus-host disease, according to a Friday Australian bourse filing.The therapy was approved by the US Food and Drug Administration in December 2024. The firm is now awaiting national drug codes from the regulator, which will allow for the publication of product pricing in the US price compendia.The firm's commercial inventory has been manufactured and a distribution network has been established using specialty pharmaceutical services and distribution firm Cencora.Its commercial launch strategy will initially target centers with experience using the therapy at high volume, followed by a broader staged rollout.The firm has been working on finalizing product availability, including logistics, regulatory documentation, and contractual arrangements ahead of the launch, its chief executive Silviu Itescu sa","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7501","MESO","BK4139","BK7508","MSB.AU"],"gpt_icon":0},{"id":"2507898875","title":"Why Lendlease, Mesoblast, St Barbara, and Zip shares are pushing higher","url":"https://stock-news.laohu8.com/highlight/detail?id=2507898875","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507898875?lang=en_us&edition=fundamental","pubTime":"2025-01-31 09:10","pubTimestamp":1738285801,"startTime":"0","endTime":"0","summary":"In early afternoon trade, theS&P/ASX 200 Index (ASX: XJO) is on track to end the week with a solid gain. At the time of writing, the benchmark index is up 0.5% to 8,538.5 points. Four ASX shares that ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/31/why-lendlease-mesoblast-st-barbara-and-zip-shares-are-pushing-higher/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["XJO.AU","BK7506","BK7501","BK7067","BK7121","LLC.AU","MESO","ZIP.AU","BK7093","SBM.AU","BK7508","BK7104","MSB.AU","BK4139"],"gpt_icon":0},{"id":"2507998983","title":"Up 1,090% in a year, why is the Mesoblast share price leaping higher again on Friday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2507998983","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507998983?lang=en_us&edition=fundamental","pubTime":"2025-01-31 09:04","pubTimestamp":1738285492,"startTime":"0","endTime":"0","summary":"Commenting on the results sending the Mesoblast share price higher again today, CEO Silviu Itescu said, \"We are committed to making our FDA-approved product Ryoncil available as quickly as possible to the many children with SR-aGVHD in need of life-saving therapy.\" Itescu added:  The team has been working relentlessly on finalising product availability, including logistics, regulatory documentation, and contractual arrangements to ensure a successful launch of Ryoncil this quarter.  On the financing front, Itescu said:  The successful financing of US$160 million this month, which provides the company with proforma cash on hand of approximately US$200 million, puts us in a strong position to execute the US commercial launch activities of Ryoncil, to expand the clinical indications of the product, and ensure that commercial manufacturing will meet projected product uptake and demand.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/31/up-1090-in-a-year-why-is-the-mesoblast-share-price-leaping-higher-again-on-friday/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["MESO","MSB.AU","BK7501","BK4139","BK4150","XKO.AU","BK7067","MSC","BK7508","BK4575"],"gpt_icon":0},{"id":"2507577603","title":"$1,000 invested in Mesoblast shares at the start of 2024 is now worth…","url":"https://stock-news.laohu8.com/highlight/detail?id=2507577603","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507577603?lang=en_us&edition=fundamental","pubTime":"2025-01-31 05:08","pubTimestamp":1738271293,"startTime":"0","endTime":"0","summary":"Let's dig a little deeper into things. Why did its shares rocket?Bell Potter still sees scope for Mesoblast's shares to keep rising. Its analysts recently put a speculative buy rating and $3.90 price target on them. It said:  The approval of Ryoncil has been transformational for the company with an exciting pipeline of products to follow. We retain our Buy  rating with valuation increased to $3.90  owing largely to the de-riskin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/31/1000-invested-in-mesoblast-shares-at-the-start-of-2024-is-now-worth/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7508","BK4139","BK4150","MESO","BK7501","BK7067","MSB.AU","BK4575","MSC"],"gpt_icon":0},{"id":"2506374775","title":"Why Mesoblast (MESO) Is Among the Best Australian Stocks to Buy Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2506374775","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506374775?lang=en_us&edition=fundamental","pubTime":"2025-01-27 21:03","pubTimestamp":1737983016,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 10 Best Australian Stocks to Buy Now.In this article, we are going to take a look at where Mesoblast Limited  stands against other best Australian stocks to buy now.According to a report by Vanguard published on January 24, Australia’s economy is expected to experience a gradual recovery in 2025, following its slowest growth in 32 years in 2024. The report forecasts an economic growth of 2% year over year by the end of 2025, with trimmed mean inflation, a core measure that excludes items at the extremes, expected to reach 2.5% year over year. However, the report notes that low productivity growth and higher unit labor costs will keep core inflation from falling sustainably to the midpoint of the Reserve Bank of Australia’s  2%–3% target range until later in 2025.Why do we care about what hedge funds do?The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-mesoblast-meso-among-best-130336424.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["RBA","QLD","BK4139","BK7501","BK7508","NVIW.SI","LU2098885051.SGD","TSYW.SI","XAO.AU","BK7067","LU0757428866.USD","QID","BK7104","TQQQ","BK4137","MSB.AU","USAW.SI",".IXIC","LU1303367103.USD","PSQ","USJW.SI","TAM.AU","LU1815336091.USD","SQQQ","NQmain","MNQmain","XJO.AU","XKO.AU","MESO","IBD"],"gpt_icon":1},{"id":"2505011420","title":"3 ASX Growth Stocks With High Insider Ownership Seeing Up To 55% Earnings Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2505011420","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505011420?lang=en_us&edition=fundamental","pubTime":"2025-01-24 12:01","pubTimestamp":1737691293,"startTime":"0","endTime":"0","summary":"As the ASX200 experiences its third consecutive weekly gain, buoyed by a softer US stance on tariffs and calls for lower oil prices and interest rates, investors are keenly observing sectors like Discretionary and Real Estate that have shown robust performance. In this favorable environment, growth companies with substantial insider ownership can offer unique insights into potential earnings expansion, as insiders' vested interests often align closely with shareholder value creation.Top 10 Growth Companies With High Insider Ownership In Australia. Click here to see the full list of 91 stocks from our Fast Growing ASX Companies With High Insider Ownership screener.Aussie Broadband is experiencing significant earnings growth, projected at 23.2% annually, outpacing the broader Australian market. Despite a slower revenue growth forecast of 8.6%, it remains above the market average. Recent insider activity shows more buying than selling, although no substantial purchases occurred in the pas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-asx-growth-stocks-high-040133112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["EMR.AU","ABB.AU","MSB.AU","MESO"],"gpt_icon":0},{"id":"2505024706","title":"Bullish Mesoblast Insiders Loaded Up On US$145.4m Of Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2505024706","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505024706?lang=en_us&edition=fundamental","pubTime":"2025-01-24 05:57","pubTimestamp":1737669458,"startTime":"0","endTime":"0","summary":"Multiple insiders secured a larger position in Mesoblast Limited  shares over the last 12 months. This is reassuring as this suggests that insiders have increased optimism about the company's prospects.While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing.It is good to see recent purchasing. We also take confidence from the longer term picture of insider transactions. But we don't feel the same about the fact the company is making losses. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Mesoblast. O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/bullish-mesoblast-insiders-loaded-us-215738998.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MSB.AU","MESO","BK7067","BK7508","BK4139","BK7501"],"gpt_icon":1},{"id":"2505073164","title":"Up 19% in a month, what's driving Mesoblast shares?","url":"https://stock-news.laohu8.com/highlight/detail?id=2505073164","media":"MotleyFool","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505073164?lang=en_us&edition=fundamental","pubTime":"2025-01-22 07:26","pubTimestamp":1737502001,"startTime":"0","endTime":"0","summary":"Following the FDA approval, Mesoblast completed a $260 million capital raising, priced at $2.50 per share.  As we reported at the time, this was a 47% premium to its share price just a month earlier. Management said the funds would support the commercial launch of Ryoncil in the US and further clinical developments. These include the \"acceleration\" of the second Phase 3 trial investigating Ryoncil for treating inflammatory chronic low back pain. Phase 3 trials are the final stage for any treatment before it is approved for the US market. Management also said it would use part of the funds to expand its manufacturing capacity, to meet the expected demand for these therapies if they were approved. As for broker ratings, the stock is rated a buy from the consensus of analyst estimates, according to CommSec.  The average price target amongst these analysts is $3.79 apiece, as per Tradingview broker data. This implies a 32% upside potential from Mesoblast's closing price on Tuesday. Fool","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/22/up-19-in-a-month-whats-driving-mesoblast-shares/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7501","BK7067","MSB.AU","BK4139","MESO","BK7508"],"gpt_icon":0},{"id":"2505260805","title":"Mesoblast shares dip then flip on $800,000 insider buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2505260805","media":"MotleyFool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505260805?lang=en_us&edition=fundamental","pubTime":"2025-01-21 09:17","pubTimestamp":1737422246,"startTime":"0","endTime":"0","summary":"Mesoblast Ltd shares started Tuesday trading in the red before reversing direction amid news of a major company insider purchase. The Mesoblast share price is $2.81, up 1.08% at the time of writing. The ASX biotechshare is outperforming the S&P/ASX All Ordinaries Index, which is up 0.36%. What's been happening lately?) on 2 January. Are Mesoblast shares a buy?For now, John Athanasiou of Red Leaf Securities has a hold rating on Mesoblast shares.  He recommends that existing shareholders and poten","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com.au/2025/01/21/mesoblast-shares-dip-then-flip-on-800000-insider-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"motleyfoolau_stock","symbols":["BK7067","MESO","BK7508","BK7501","BK7016","XAO.AU","BK4139","ADS.AU","MSB.AU"],"gpt_icon":0},{"id":"2503106676","title":"Caution! 11 stocks on the ‘avoid’ list for 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2503106676","media":"LiveWire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503106676?lang=en_us&edition=fundamental","pubTime":"2025-01-16 04:00","pubTimestamp":1736971228,"startTime":"0","endTime":"0","summary":"You can watch the video by clicking the player, listen to the podcast, or read an edited transcript below. These interviews were filmed on Tuesday, 10 December 2024.Everyone is hunting for the next big winner in the stock market, but sometimes it pays to go back to basics. Where is a better place to start than by drawing on the wisdom of the Oracle of Omaha, Warren Buffett?Note: We would like to thank the fund managers listed above for sharing their top ideas for 2025 in the spirit of the Outlook Series. All of the fund managers featured in this series run diversified portfolios and do not invest solely in the stocks mentioned below. This list is not, nor is it intended to be, a set of recommendations. Please do your own research and seek advice from a professional before making any investment decisions of your own. Past performance is not a reliable indi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"livewire_stock","url":"https://www.livewiremarkets.com/wires/caution-11-stocks-on-the-avoid-list-for-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.livewiremarkets.com/wires/caution-11-stocks-on-the-avoid-list-for-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"livewire_stock","symbols":["IE0005OL40V9.USD","MMS.AU","USJW.SI","EQNR","LU0820562030.AUD","LU1815333072.USD","BK7128","LU2242649171.HKD","LU0096362180.USD","LU2592432038.USD","BK4532","LU0823434740.USD","LU0345770993.USD","BK4548","LU1917777945.USD","LU0107464264.USD","LU0154236417.USD","IE0034235188.USD","LU0994945656.USD","LU1066051225.USD","PWR.AU","NXT.AU","IE00B5949003.HKD","LU1935043023.USD","BRN.AU","LU1267930813.SGD","LU0323591593.USD","LOV.AU","LU0203347892.USD","LU2458330169.SGD","IE0034235303.USD","GOOGL","LU0310799852.SGD","LU0792757196.USD","LU2491050154.USD","MSB.AU","LU0943347566.SGD","LU0724617625.USD","LU0787776722.HKD","LU1868836914.USD","LU0234572021.USD","SIQ.AU","LU1852331112.SGD","LU0077335932.USD","LU1267930227.SGD","LU0149725797.USD","GOOG","IPH.AU","APE.AU","LU2065171402.SGD"],"gpt_icon":1}],"pageSize":16,"totalPage":10,"pageCount":3,"totalSize":160}]}}